Skip to main content

Table 2 Patient’s characteristics

From: Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

Characteristic

Nb of patient (%)

Nb of registered and treated patients

17

Age (years)

 

Median

59

Range

44 - 75

Gender

 

Male

9 (53)

Female

8 (47)

WHO performance status

 

0

3 (18%)

1

12 (70%)

2

2 (12%)

Type of cancer

 

Colon or colorectal cancer

7 (41%)

Breast cancer

5 (29%)

Ovarian cancer

2 (12%)

Non-small-cell-lung cancer

1 (6%)

Head and neck cancer

1 (6%)

Hepatocarcinoma

1 (6%)

Status disease

 

Minimal

5 (29%)

Bulky

12 (71%)

Metastatic sites

 

Liver

11 (65%)

Lung

9 (53%)

Lymph nodes

5 (29%)

Bone

3 (18%)

Skin

3 (18%)

Brain

1 (6%)

Adrenal gland

1 (6%)

Previous lines of chemotherapy

 

Median

5

Range

1 - 11

Distance by last chemotherapy

 

Median (months)

1,5

Range

1 - 18